Navigation Links
New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
Date:11/9/2010

i>In controlled Crohn's clinical trials, the most common adverse events that occurred in greater than or equal to 5% of certolizumab Pegol patients (n=620) and more frequently than with placebo (n=614) were upper respiratory infection (20% certolizumab pegol, 13% placebo), urinary tract infection (7% certolizumab pegol, 6% placebo), and arthralgia (6% certolizumab pegol, 4% placebo).  The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for certolizumab pegol and 7% for placebo.

In controlled RA clinical trials, the most common adverse events that occurred in greater than or equal to 3% of patients taking certolizumab pegol 200 mg every other week with concomitant methotrexate (n=640) and more frequently than with placebo with concomitant methotrexate (n=324) were upper respiratory tract infection (6% certolizumab pegol, 2% placebo), headache (5% certolizumab pegol, 4% placebo), hypertension (5% certolizumab pegol, 2% placebo), nasopharyngitis (5% certolizumab pegol, 1% placebo), back pain (4% certolizumab pegol, 1% placebo), pyrexia (3% certolizumab pegol, 2% placebo), pharyngitis (3% certolizumab pegol, 1% placebo), rash (3% certolizumab pegol, 1% placebo), acute bronchitis (3% certolizumab pegol,1% placebo), fatigue (3% certolizumab pegol, 1% placebo).  Hypertensive adverse reactions were observed more frequently in patients receiving certolizumab pegol than in controls.  These adverse reactions occurred more frequently among patients with a baseline history of hypertension and among patients receiving concomitant corticosteroids and nonsteroidal anti-inflammatory drugs.  Patients receiving certolizumab pegol 400mg as monotherapy every 4 weeks in RA controlled clinical trials had similar adverse reactions to those patients receiving certolizumab pegol 200mg every other week. The proportion of patients who discontinued treatment due to adverse reactions in the
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
2. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
3. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
4. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
5. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
6. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
7. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
11. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... PAUL, Minn. , June 30, 2015  EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... of its previously announced public offering  of 40,229,886 units. ... 0.50 of a Series A warrant to purchase one ... B warrant to purchase one share of common stock, ...
(Date:6/30/2015)... BERKELEY, Calif. and ... CMC Biologics, Inc. , a global leader in ... therapeutic proteins, announced today that, as part of its ... expansion of its North American manufacturing facility in ... a single-use Bioreactor 6Pack™ facility.  The Bioreactor 6Pack™ configuration ...
(Date:6/29/2015)... 2015 Mordor Intelligence presents their ... Material (Plastic, Glass, Paper, Metal) - ByType of Packaging (Ampules, ... Tubes, Vials, Sachets) - By Geographical Region ( North ... Asia Pacific , Latin America , ... ) - discussing Industry Value Chain Analysis, Porter,s 5 ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... PRINCETON, N.J., Jan. 4, 2011 Pharmasset, Inc. (Nasdaq: ... 29th Annual J.P. Morgan Healthcare Conference to be held January ... CA. Schaefer Price, President and Chief Executive Officer, will provide ... at 9:00 AM (PT). To access a simultaneous ...
... Jan. 4, 2011 Boston Scientific Corporation (NYSE: ... M.D., Chief Medical Officer, Cardiac Rhythm Management, on an article ... the American Medical Association .  The article reported on a ... received an implantable cardioverter defibrillator (ICD) did not meet evidence-based ...
Cached Medicine Technology:Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference 2Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference 3Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article 2
(Date:6/30/2015)... ... June 30, 2015 , ... Memphis, TN: Electronic Security ... ranked as one of their top 20 installing dealers for the first quarter ... Providers are based on timeliness, service, installation, paperwork and customer satisfaction. , ESSC ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down announces that they have slashed ... at the legendary Pantages Theatre. For the past 26 years, “The Phantom of ... In 1988, this musical, originally written by Gaston Leroux, and converted into a musical by ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Ticket Down is a reliable source for last ... This legendary band has been packing stadiums across North America in conjunction with their 2015 ... they have the energy of a band in their twenties. Some of the most ...
(Date:6/30/2015)... ... June 30, 2015 , ... The board certified otolaryngologists at ... website to inform potential sinus surgery patients about ear, nose, and throat (ENT) ... about a wide variety of ENT issues including hearing loss, ear infections, dizziness, ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Blue Cross and Blue ... 24 projects across the state. The projects improve community health by focusing on the ... $100,000 and many are renewable for a second year in 2016 based on progress ...
Breaking Medicine News(10 mins):Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2
... AGA Medical Corporation,(AGA), a privately-held medical device manufacturer, ... in connection with corrupt payments to Chinese,government officials ... Acting Assistant Attorney General Matthew Friedrich announced,today., ... with AGA,and filed a criminal information against the ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ) updates and ... in 2008 are estimated to be,$12.5 to $12.9 million ... $11.3 to $11.7 million., ABOUT VNUS MEDICAL TECHNOLOGIES, ... Jose, California, VNUS Medical,Technologies is a worldwide leader in ...
... Co-Founders Honored for Lifetime Achievement in Public Relations, ... Inc.,one of the largest independent public relations agencies, ... Schwartz, were honored with the,2008 John J. Malloy ... Publicity Club of New England,s Bell Ringer Awards., ...
... chemotherapy treatments for what doctors say is a ... News) -- Sen. Edward M. Kennedy enjoyed "a ... of Duke University Medical Center on Tuesday, one ... "successful" three-and-a-half-hour surgery to treat his malignant brain ...
... of rheumatoid arthritis (RA), a chronic, inflammatory joint ... antirheumatic drugs (DMARDs). In addition to trusted ... promise to improve treatment for RA. The American ... devotion to fostering excellence in patient care, has ...
... 100% juice, but not all experts agree with findings , , ... percent fruit juices apparently don,t tend to be overweight, and ... drink the beverages, a new study finds. , "We found ... Theresa A. Nicklas, a professor of pediatrics at Baylor College ...
Cached Medicine News:Health News:AGA Medical Corporation Agrees to Pay $2 Million Penalty and Enter Deferred Prosecution Agreement for FCPA Violations 2Health News:Steve and Paula Mae Schwartz Honored With Publicity Club of New England's Crystal Bell Award 2Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 2Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 3Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 4Health News:American College of Rheumatology presents recommendations for rheumatoid arthritis therapy 2Health News:American College of Rheumatology presents recommendations for rheumatoid arthritis therapy 3Health News:Fruit Juice May Be Healthy for Kids: Study 2Health News:Fruit Juice May Be Healthy for Kids: Study 3
Sleeve extends 3mm beyond end, .90mm (20G) probe, 1.4mm (17G) sleeve...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
Ideal for short scleral tunnel and trabecular meshwork incisions...
Rounded tip for even incisions reducing post-op astigmatism...
Medicine Products: